American National Insurance’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$690K Sell
9,450
-2,150
-19% -$144K 0.19% 159
2021
Q4
$723K Sell
11,600
-68,573
-86% -$4.02M 0.16% 181
2021
Q3
$4.74M Sell
80,173
-70
-0.1% -$4.61K 0.18% 160
2021
Q2
$5.36M Sell
80,243
-115
-0.1% -$7.5K 0.2% 147
2021
Q1
$5.07M Sell
80,358
-62
-0.1% -$3.86K 0.21% 142
2020
Q4
$4.99M Hold
80,420
0.21% 136
2020
Q3
$4.85M Hold
80,420
0.23% 118
2020
Q2
$4.73M Hold
80,420
0.24% 113
2020
Q1
$4.48M Hold
80,420
0.29% 102
2019
Q4
$5.16M Buy
+80,420
New +$4.61M 0.27% 109

Other funds holding BMY

American National Insurance's BMY Position: Q1 2022 in Review

American National Insurance reduced its Bristol-Myers Squibb (BMY) stake by 19% in Q1 2022, selling an estimated $144K and leaving 9,450 shares worth $690K. The position accounts for 0.19% of the portfolio, ranked #159.

American National Insurance first reported a position in BMY in Q4 2019 and has held it in 10 quarters since. The position peaked at $5.36M in Q2 2021. 2,515 funds tracked by Wall St. Rank hold BMY as of Q1 2022.

  • American National Insurance held 9,450 shares of Bristol-Myers Squibb worth $690K as of Q1 2022.
  • American National Insurance sold 2,150 Bristol-Myers Squibb shares in Q1 2022, an estimated $144K.
  • Bristol-Myers Squibb made up 0.19% of American National Insurance's portfolio in Q1 2022, its #159 holding.
  • American National Insurance first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 10 quarters since.
  • American National Insurance's Bristol-Myers Squibb position peaked at $5.36M in Q2 2021.
  • 2,515 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2022.

Based on American National Insurance's 13F filing for Q1 2022, filed 13 May 2022.